Výsledky vyhledávání - Daniel Canter
- Zobrazuji výsledky 1 - 18 z 18
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Nephron‐sparing management vs radical nephroureterectomy for low‐ or moderate‐grade, low‐stage upper tract urothelial carcinoma Autor Jay Simhan, Marc C. Smaldone, Brian L. Egleston, Daniel Canter, Steven Sterious, Anthony T. Corcoran, Serge Ginzburg, Robert G. Uzzo, Alexander Kutikov
Vydáno 2013Artigo -
8
Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy Autor Jay Simhan, Marc C. Smaldone, Kevin Tsai, Daniel Canter, Tianyu Li, Alexander Kutikov, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo
Vydáno 2011Artigo -
9
-
10
Growth Kinetics and Short-Term Outcomes of cT1b and cT2 Renal Masses under Active Surveillance Autor Reza Mehrazin, Marc C. Smaldone, Alexander Kutikov, Tianyu Li, Jeffrey Tomaszewski, Daniel Canter, Rosalia Viterbo, Richard E. Greenberg, David Y.T. Chen, Robert G. Uzzo
Vydáno 2014Artigo -
11
Assessing Performance Trends in Laparoscopic Nephrectomy and Nephron-sparing Surgery for Localized Renal Tumors Autor Marc C. Smaldone, Alexander Kutikov, Brian L. Egleston, Jay Simhan, Daniel Canter, Ervin Teper, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo
Vydáno 2012Artigo -
12
Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma Autor Daniel M. Geynisman, Elizabeth A. Handorf, Yu‐Ning Wong, Jamie Doyle, Elizabeth R. Plimack, Eric M. Horwitz, Daniel Canter, Robert G. Uzzo, Alexander Kutikov, Marc C. Smaldone
Vydáno 2015Artigo -
13
Utility of the R.E.N.A.L. Nephrometry Scoring System in Objectifying Treatment Decision-making of the Enhancing Renal Mass Autor Daniel Canter, Alexander Kutikov, Brandon J. Manley, Brian L. Egleston, Jay Simhan, Marc C. Smaldone, Ervin Teper, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo
Vydáno 2011Artigo -
14
Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score Autor Alexander Kutikov, Marc C. Smaldone, Brian L. Egleston, Brandon J. Manley, Daniel Canter, Jay Simhan, Stephen A. Boorjian, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo
Vydáno 2011Artigo -
15
Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial Autor Johann S. de Bono, He Meng, Zhen Shi, Małgorzata Nowicka, Sergio Bracarda, Cora N. Sternberg, Kim N., David Olmos, Shahneen Sandhu, Christophe Massard, Nobuaki Matsubara, Geng Chen, Nives Selak Bienz, Daniel Canter, Matthew Wongchenko, Christopher J. Sweeney
Vydáno 2025Artigo -
16
Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study Autor Neal D. Shore, Stephen A. Boorjian, Daniel Canter, Kenneth Ogan, Lawrence I. Karsh, Tracy M. Downs, Leonard G. Gomella, Ashish M. Kamat, Yair Lotan, Robert S. Svatek, Trinity J. Bivalacqua, Robert L. Grubb, Tracey L. Krupski, Seth P. Lerner, Michael Woods, Brant A. Inman, Matthew I. Milowsky, Alan Boyd, F. Peter Treasure, Gillian Gregory, David G. Sawutz, Seppo Ylä‐Herttuala, Nigel Parker, Colin P. Dinney
Vydáno 2017Artigo -
17
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial... Autor Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, Joseph E. Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne Schuckman, Tracy M. Downs, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael Woods, Gordon Brown, Daniel Canter, Adam Luchey, Yair Lotan, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Sam S. Chang, Alexander I. Sankin, Michael A. O’Donnell, David G. Sawutz, Richard Philipson, Nigel Parker, Seppo Ylä‐Herttuala, Dorte Rehm, Jørn S. Jakobsen, Kristian Vinter Juul, Colin P. Dinney
Vydáno 2024Artigo -
18
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial Autor Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, Joseph E. Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne Schuckman, Tracy M. Downs, Robert S. Svatek, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael Woods, Gordon Brown, Daniel Canter, Adam Luchey, Yair Lotan, Tracey L. Krupski, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Kirk A. Keegan, Gerald L. Andriole, Alexander I. Sankin, Alan Boyd, Michael A. O’Donnell, David G. Sawutz, Richard Philipson, Ruth Coll, Vikram M. Narayan, F. Peter Treasure, Seppo Ylä‐Herttuala, Nigel Parker, Colin P. Dinney
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Cancer
Urology
Biology
Surgery
Kidney
Oncology
Bladder cancer
Nephrectomy
Prostate cancer
Clinical trial
Cohort
Paleontology
Physics
Renal mass
Stage (stratigraphy)
Androgen receptor
Cancer cell
Cancer research
Carcinoma
Cell biology
Chemistry
Clinical endpoint
Confidence interval
Environmental health
Gastroenterology
Logistic regression
Metastasis
Nephrology